Variables | 2-year disease-free survival rate | P | Grade III or IV toxicity n (%) | P | |
---|---|---|---|---|---|
Gender | Male (n = 24) | 75% | 0.68 | 6 (25.0) | 0.33 |
Female (n = 16) | 74% | 2 (12.5) | |||
Age | ≥65 (n = 13) | 82% | 0.29 | 1 (7.7) | 0.18 |
<65 (n = 27) | 50% | 7 (25.9) | |||
Histological type | Diffuse type (n = 25) | 74% | 0.57 | 6 (24.0) | 0.41 |
Intestinal type (n = 15) | 75% | 2 (13.3) | |||
ECOG performance status scale | 0 (n = 32) | 74% | 0.63 | 6 (18.8) | 0.74 |
1 to 2 (n = 8) | 75% | 2 (25.0) | |||
Type of gastrectomy | Total (n = 15) | 72% | 0.66 | 6 (40.0) | 0.014 |
Subtotal (n = 25) | 76% | 2 (8.0) | |||
T stage | 1 to 2 (n = 28) | 82% | 0.44 | 6 (21.4) | 0.73 |
3 to 4 (n = 12) | 75% | 2 (16.7) | |||
Lymph node metastases numbers | 0 to 15 (n = 34) | 91% | <0.001 | 0 (0) | 0.18 |
>15 (n = 6) | 17% | (HR 0.09, 95% CI 0.02, 0.40) | 8 (23.5) |